source name	characteristics[organism]	characteristics[organism part]	characteristics[age]	characteristics[strain]	characteristics[developmental stage]	characteristics[cell line]	characteristics[sample type]	characteristics[cell type]	characteristics[sex]	characteristics[disease]	characteristics[phenotype]	characteristics[biological replicate]	Material Type	assay name	technology type	comment[data file]	comment[file uri]	comment[technical replicate]	comment[fraction identifier]	comment[label]	comment[instrument]	comment[modification parameters]	comment[modification parameters].1	comment[modification parameters].2	comment[cleavage agent details]	comment[dissociation method]	comment[collision energy]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	Factor Value[cell line]
PXD006439-Sample-10	Mus musculus	skin	not available	C57BL/6J	not available	B16-F10	16K EV	not available	not available	high metastatic potential	Malignant	1	cell	run 46	proteomic profiling by mass spectrometry	QE2_160128_OPL4022_SCS_EVs_and_LYS_H1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_H1.raw	1	1	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	AC=MS:1001313;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	25% NCE	4.5 ppm	20 ppm	B16-F10
PXD006439-Sample-10	Mus musculus	skin	not available	C57BL/6J	not available	B16-F10	16K EV	not available	not available	high metastatic potential	Malignant	1	cell	run 47	proteomic profiling by mass spectrometry	QE2_160128_OPL4022_SCS_EVs_and_LYS_H2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_H2.raw	1	2	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	AC=MS:1001313;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	25% NCE	4.5 ppm	20 ppm	B16-F10
PXD006439-Sample-10	Mus musculus	skin	not available	C57BL/6J	not available	B16-F10	16K EV	not available	not available	high metastatic potential	Malignant	1	cell	run 48	proteomic profiling by mass spectrometry	QE2_160128_OPL4022_SCS_EVs_and_LYS_H3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_H3.raw	1	3	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	AC=MS:1001313;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	25% NCE	4.5 ppm	20 ppm	B16-F10
PXD006439-Sample-10	Mus musculus	skin	not available	C57BL/6J	not available	B16-F10	16K EV	not available	not available	high metastatic potential	Malignant	1	cell	run 49	proteomic profiling by mass spectrometry	QE2_160128_OPL4022_SCS_EVs_and_LYS_H4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_H4.raw	1	4	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	AC=MS:1001313;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	25% NCE	4.5 ppm	20 ppm	B16-F10
PXD006439-Sample-10	Mus musculus	skin	not available	C57BL/6J	not available	B16-F10	16K EV	not available	not available	high metastatic potential	Malignant	1	cell	run 50	proteomic profiling by mass spectrometry	QE2_160128_OPL4022_SCS_EVs_and_LYS_H5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_H5.raw	1	5	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	AC=MS:1001313;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	25% NCE	4.5 ppm	20 ppm	B16-F10
